Skip to content
Medical Health Aged Care

Vale John Daffey FPS

Pharmaceutical Society of Australia (PSA) < 1 mins read

The Pharmaceutical Society of Australia (PSA) is deeply saddened to hear of the passing of former National President John Daffey FPS.  

Mr Daffey served as PSA’s National President between 2000 and 2001, on top of his 15 years of service on PSA’s Victorian Branch from 1987 to 2002.   

PSA National President Dr Fei Sim FPS expressed her deepest condolences to Mr Daffey’s colleagues, family, friends and loved ones.   

“John made many valuable contributions to our profession, both as a community pharmacist and as a national leader,” Dr Sim said.   

“John is well known for his leadership and collegiality throughout negotiations for the 3rd Community Pharmacy Agreement, working collaboratively with the Pharmacy Guild of Australia to get the best outcomes for Australian pharmacists and patients.  

“His loss comes at a difficult time for pharmacists around Australia, and there has never been a more important time for our profession to unite in John’s spirit of solidarity.  

“On behalf of the pharmacy profession, my deepest condolences are with the Daffey family, their friends, and many colleagues in Victoria,” Dr Sim concluded. 

 

Media contact:   Georgia Clarke   M: 0480 099 798      E: [email protected]

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s 36,000 pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system.

More from this category

  • Medical Health Aged Care
  • 17/12/2025
  • 13:11
GE HealthCare

GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners

300+ advanced CT scanners to be installed in public hospitals across 38 provinces by 2028, to support early diagnosis and treatment of non-communicable diseases.…

  • Contains:
  • Finance Investment, Medical Health Aged Care
  • 17/12/2025
  • 12:03
Jane Morgan Management

LTR Pharma surpasses 1,000 SPONTANĀ® prescriptions under TGA Special Access Scheme

Highlights More than 1,000 SPONTAN® prescriptions issued under the TGA Special Access Scheme Growing prescriber network with continued uptake in complex ED cases, including post-prostate cancer patients Real-world insights informing US commercial strategy ahead of ROXUS® launch in H1 CY2026 LTR Pharma Limited (ASX:LTP) (“LTR Pharma” or “the Company”) is pleased to announce that more than 1,000 SPONTAN® prescriptions have now been issued in Australia under the Therapeutic Goods Administration (TGA) Special Access Scheme (SAS Category B). SPONTAN is being prescribed for patients with unmet clinical needs, including men who have not achieved adequate benefit from traditional oral PDE5 inhibitor…

  • Contains:
  • Engineering, Medical Health Aged Care
  • 17/12/2025
  • 09:02
UNSW Sydney

UNSW students claim victory in international artificial heart competition

A team of undergraduate engineering students from UNSW Sydney has claimed first place at a prestigious international artificial heart design competition in Vienna. The…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.